Journal
INFLAMMOPHARMACOLOGY
Volume 22, Issue 3, Pages 179-185Publisher
SPRINGER BASEL AG
DOI: 10.1007/s10787-013-0182-8
Keywords
Solanum cernuum Vell.; 31-Norcycloartanones; Analgesic; Anti-inflammatory; COX-2
Categories
Funding
- Andalucia Government, Spain - Proyecto de Excelencia-Polfanat [P09-AGR- 5185]
- Programa de Mestrado em Uso Racional de Medicamentos of the Universidade de Sorocaba (Brazil)
Ask authors/readers for more resources
Cycloeucalenone (1) and 24-oxo-31-norcycloartanone (2) obtained from Solanum cernuum Vell. were assayed to explore their pharmacologic roles. Previous studies showed that (2) has selective activity against lung tumor cell line (NCIH460) which expresses high levels of COX-2, suggesting its role in inflammatory process, and also a link between chronic inflammation and cancer-associated process. Dichloromethane crude extract (DCE) significantly reduced writhing and stretching induced by 0.8 % acetic acid at a dose of 100, 300, and 600 mg/kg, po; oral administration of different doses of (1) and (2) also displayed significant analgesic and anti-inflammatory effects in the writhing acetic acid test (p < 0.0001). Selected oral doses of both compounds (100 and 50 mg/kg) were assayed in the carrageenan-induced paw edema model. Compound (2) showed significant activity during the early phase (1.5-6 h) and also in the late phase (48 h) (p < 0.01). The anti-nociceptive activity observed for the compounds (1) and (2) and DCE was found to be related to the inhibition of different mediators involved in inflammation and nociceptive process. Both compounds decrease COX-2 protein expression, although only compound (2) reached a significant response (p < 0.05 vs control). However, in vitro Sirtuin 1 activity and TNF-alpha production in THP-1 macrophages were not affected.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available